iannis aifantis T Cell Leukemia
Iannis Aifantis/LinkedIn

Iannis Aifantis: The pre-T Cell Receptor as an Immunotherapy Target in T Cell Leukemia

Iannis Aifantis, Chairman of the Department of Pathology at NYU School of Medicine, shared a post on X:

“You can never forget your first love!!

It took me back almost 25 years but it was a lot of fun to write (together with Ali Rosen in the lab) this News and Views for the fantastic story by Maria Toribio and colleagues on the pre-TCR as an immunotherapy target in T cell leukemia.”

Iannis Aifantis: The pre-T Cell Receptor as an Immunotherapy Target in T Cell Leukemia

Title: The pre-T cell receptor as a tumor immunotherapy target in T cell leukemia

Authors: Aliza Rosen, Iannis Aifantis

Read The Full Article at Nature Immunology.

Iannis Aifantis: The pre-T Cell Receptor as an Immunotherapy Target in T Cell Leukemia

More Posts Featuring Iannis Aifantis.